Off-label prescribing in a French hospital

被引:16
|
作者
Cras, Audrey
Marie-Agnes Conscience
Rajzbaum, Gerald
Louet, Agnes Lillo-Le
Lopez, Nathalie
Tersen, Isabelle
Bezie, Yvonnick
机构
[1] St Joseph Hosp Fdn, Dept Pharm, F-75014 Paris, France
[2] St Joseph Hosp Fdn, Dept Rheumatol, F-75014 Paris, France
[3] Georges Pompidou European Hosp, Dept Pharmacol, F-75015 Paris, France
来源
PHARMACY WORLD & SCIENCE | 2007年 / 29卷 / 02期
关键词
adverse drug reactions; France; hospital; off-label prescribing; prescribing;
D O I
10.1007/s11096-006-9064-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective In contrast to paediatrics patients, data concerning the extent of off-label prescribing for adult patients are limited. The aim of our study was to investigate the frequency of off-label drug use for adult patients in a French general hospital. Method The study was conducted on a Wednesday in November 2004. Prescribing was prospectively assessed on the basis of conformity with the marketing authorizations. Results A total of 1341 prescriptions for 192 hospitalized patients were analysed. Twenty three per cent of the prescriptions were off-label. Among all patients, 70% received at least one off-label medicine. Most off-label prescriptions were related to an unapproved indication (75%). The main other reasons were dosage (14%) and dosing schedule (9%). Anti-thrombotic and anti-ulcer agents were found on more than 40% of the off-label prescriptions. Conclusion Off-label prescriptions occur frequently in the hospital and often alternatives with the proper marketing authorizations are available. An increased involvement of hospital pharmacists should reduce the incidence of off-label prescribing and thus contribute to patient safety and possibly cost reduction.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 50 条
  • [1] Off-label prescribing in a French hospital
    Audrey Cras
    Marie-Agnès Conscience
    Gérald Rajzbaum
    Agnès Lillo-Le Louët
    Nathalie Lopez
    Isabelle Tersen
    Yvonnick Bezie
    [J]. Pharmacy World & Science, 2007, 29 : 97 - 100
  • [2] Impact of hospital stay on the frequency of off-label prescribing in a French Hospital
    Cras, Audrey
    Ferderspiel, Florence
    Guitteau, Carole
    Tersen, Isabelle
    Rajzbaum, Gerald
    Bezie, Yvonnick
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 501 - 501
  • [3] Off-label prescribing in a German psychiatric hospital
    Assion, H. J.
    Jungck, C.
    [J]. PHARMACOPSYCHIATRY, 2007, 40 (01) : 30 - 36
  • [4] Off-label prescribing
    Seale, J. Paul
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (02) : 65 - 65
  • [5] Off-label prescribing
    Gazarian, Madlen
    Morris, Steve
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (11) : 637 - 637
  • [6] Off-label prescribing
    Kelly, Maria
    Gazarian, Madlen
    McPhee, John
    [J]. AUSTRALIAN PRESCRIBER, 2005, 28 (01) : 7 - 7
  • [7] Off-label prescribing
    Raknes, Guttorm
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (04) : 335 - 335
  • [8] OFF-LABEL PRESCRIBING OF ANTIDEPRESSANTS Robust systems are needed for off-label prescribing
    Ross, Samantha
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [9] Attitudes and experiences of off-label prescribing among paediatricians in a French university teaching hospital
    Joret, P.
    Bataille, J.
    Prot-Labarthe, S.
    Brion, F.
    Hartmann, J. -F.
    Bourdon, O.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1293 - 1294
  • [10] Off-label prescribing in oncology
    Poole, SG
    Dooley, MJ
    [J]. SUPPORTIVE CARE IN CANCER, 2004, 12 (05) : 302 - 305